N-[4-(5-Methyl-3-phenyl-oxazol-4-yl)phenyl]sulfonylpropanamide

CAS: 198470-84-7

Ref. 3D-FP29043

Product Information

• Name: N-[4-(5-Methyl-3-phenyl-oxazol-4-yl)phenyl]sulfonylpropanamide
• Synonyms: ParecoxibValus-PDynastat, Dynastat, N-((p-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)propionamide, N-[4-(5-methyl-3-phenyl-oxazol-4-yl)phenyl]sulfonylpropanamide, N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanamide, N-{[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}propanamide, Parecoxib [USAN:INN:BAN], Propanamide, N-((4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)-, Sc 69124, Unii-9Tuw81Y3Ce, Valus-P, Vorth-P, Xapit, Parecoxib

Description

N-[4-(5-Methyl-3-phenyl-oxazol-4-yl)phenyl]sulfonylpropanamide (NSO) is a drug with both antibiotic and anti-inflammatory properties. It is a potent inhibitor of the transcriptional activity of the polymerase chain reaction (PCR), and it has been shown to have low toxicity in experimental models. NSO has been used to treat treatment resistant schizophrenia, as well as postoperative pain, and has also been found to be effective for inflammatory lesions. The chemical structure of NSO consists of a pyridine ring, an oxazole ring, and an amide group. The molecular weight of NSO is 250.14 g/mol, and its chemical name is N-[4-(5-methyl-3-phenyloxazol-4-yl)phenyl]sulfonylpropanamide. It was first synthesized by Gertsch et al., in

• Brand: Biosynth

Chemical properties

• Molecular weight: 370.42 g/mol
• Formula: C₁₉H₁₈N₂O₄S
• Purity: Min. 95%
• InChI: InChI=1S/C19H18N2O4S/c1-3-17(22)21-26(23,24)16-11-9-14(10-12-16)18-13(2)25-20-19(18)15-7-5-4-6-8-15/h4-12H,3H2,1-2H3,(H,21,22)
• InChI key: InChIKey=TZRHLKRLEZJVIJ-UHFFFAOYSA-N
• SMILES: CCC(=O)NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1